SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Santen Plans Buyback of Up to 5% of Its Shares

Santen Pharmaceutical plans to repurchase up to 5% of its own shares.

Related stories